XML 23 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Earnings (Loss) Per Common Share
 6 Months Ended
Jun. 30, 2012
Earnings (Loss) Per Common Share [Abstract]  
Earnings (Loss) Per Common Share
2. Earnings (Loss) Per Common Share

Basic earnings (loss) per common share is based on the weighted average number of common shares outstanding for the three months and six months ended June 30, 2012 and 2011. Diluted earnings (loss) per share is based on the weighted average number of common shares outstanding, plus the incremental shares that would have been outstanding upon the assumed exercise of all potentially dilutive stock options and other stock units subject to anti-dilution limitations.

The following table sets forth the computation of basic and diluted earnings (loss) per common share (in thousands, except share and per share data.):

 

                                 
    Three Months Ended June 30,     Six Months Ended June 30,  
     2012     2011     2012     2011  

Net income (loss) attributable to common stockholders

   $ 761     $ (727)     $ 1,095     $ (1,049)  
   

 

 

    

 

 

    

 

 

    

 

 

  

Weighted average basic shares

     7,913,266       7,821,646       7,885,458       7,800,060  

Dilutive effect of stock options and restricted stock units (1)

     333,765       —         357,517       —    
   

 

 

    

 

 

    

 

 

    

 

 

  

Total weighted average diluted shares with assumed conversions

     8,247,031       7,821,646       8,242,975       7,800,060  
   

 

 

    

 

 

    

 

 

    

 

 

  

Earnings (loss) per common share:

                                

Basic

   $ 0.10     $ (0.09)     $ 0.14     $ (0.13)  
   

 

 

    

 

 

    

 

 

    

 

 

  

Dilutive

   $ 0.09     $ (0.09)     $ 0.13     $ (0.13)  
   

 

 

    

 

 

    

 

 

    

 

 

  

 

(1) For the three months ended and six months ended June 30, 2011, these items were excluded from diluted earnings (loss) per common share as the effect would have been anti-dilutive.